Subcutaneous abscess formation around catheters induced by viable and nonviable Staphylococcus epidermidis as well as by small amounts of bacterial cell wall components

Journal of Biomedical Materials Research

Volumn 50, Issue 4, 2000, Pages 546-556

  Boelens, Jaap Jan ^a,b   Zaat, Sebastian A J ^a   Meeldijk, Jan ^a   Dankert, Jacob ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biocompatibility; Catheter associated infection; Poly(vinylpyrrolidone); Silicone elastomer; Staphylococcus epidermidis

Indexed keywords

ELASTOMER; POVIDONE; SILICONE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CATHETER; CATHETERIZATION; CELL VIABILITY; INOCULATION; NONHUMAN; RABBIT; SKIN ABSCESS; STAPHYLOCOCCUS EPIDERMIDIS;

ABSCESS; ANIMALS; BACTERIAL ADHESION; BIOCOMPATIBLE MATERIALS; CATHETERS, INDWELLING; CELL WALL; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; PEPTIDOGLYCAN; POVIDONE; RABBITS; SILICONE ELASTOMERS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0033996559     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y     Document Type: Article

References (39)

1. Bisno AL, Waldvogel FA. Infections associated with indwelling medical devices. 2nd ed. Washington, DC: ASM; 1994.
2. Seifert H, Jansen B, Farr BM. Catheter-related infections. 1st ed. New York: Marcel Dekker; 1997. p 1-31.
3. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997;127:257-266.
4. Raad I, Hachem R, Zermeno A, Stephens LC, Bodey GP. Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device. J Infect Dis 1996;173:495-498.
5. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997;127:267-274.
6. Schierholz J, Jansen B, Jaenicke L, Pulverer G. In-vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection. Biomaterials 1994;15:996-1000.
7. Boelens JJ, Zaat SA, Tan WF, Dankert J. Release of antibacterial activity from polyvinylpyrrolidone-grafted versus conventional silicone elastomer ventriculo-peritoneal shunts. In: Program and abstracts of the 37th Interscience Conference. Abstract J-111. Toronto, Canada: ASM Press;1997. p 309.
8. Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immunol 1982;37:318-326.
9. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985;22:996-1006.
10. Peterson PK, Wilkinson Y, Kim D, Schmeling SD, Douglas PG, Quie PG, Verhoef J. The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest 1978;61:597-609.
11. Mattsson E, Verhage L, Rollof J, Fleer A, Verhoef J, Van Dijk H. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6. FEMS Immunol Med Microbiol 1993;7:281-287.
12. Mattsson E, Rollof J, Verhoef J, Van Dijk H, Fleer A. Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect Immunol 1994;62:3837-3843.
13. Timmerman CP, Mattsson E, Martinez-Martinez L, De Graaf L, Van Strijp JA, Verbrugh HA, Verhoef J, Fleer A. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect Immunol 1993;61:4167-4172.
14. Henderson B, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996;60:316-341.
15. Robinson BV, Sullivan FM, Borzelleca JF, Schwartz SL. PVP: a critical review of the kinetics and toxicology of polyvinylpyrrolidone (Povidone). 1st ed. Boca Raton, Florida: Lewis Publishers; 1990.
16. Kojima M. Morphological study on the effect of polyvinylpyrrolidone infusion upon the reticuloendothelial system. Tohoku J Exp Med 1967;92:27-54.
17. Spector WG, Heesom N, Stevens JE. Factors influencing chronicity in inflammation of rats skin. J Pathol Bacteriol 1968;96: 203-213.
18. Jovcic G, Stojanovic N, Kataranovske M, Petakov M, Obradovic P. Acute sterile inflammation - a correlation between cellular changes and extramedullary-produced regulators in vivo. Ann Hematol 1993;66:195-201.
19. van der Bogert C, Blaauw EH, Dontje BHJ, Hulstaert CE, Hardonk MJ, Kroon AM. The effect of doxycycline on polyvinylpyrrolidone-induced granuloma formation in the rat liver. Virchows Arch Cell Pathol 1986;51:39-50.
20. Vijayasekaran S, Chirila TV, Hong Y, Tahija SG, Dalton PD, Constable IJ, Mcallister IL. Poly(1-vinyl-2-pyrrolidone) hydrogels as vitreous substitutes: histopathological evaluation in the animal eye. J Biomater Sci Polym Ed 1996;7:685-696.
21. Elek SD, Conen PE. The virulence of Staphylococcus pyogenes for man. A study of the problems of wound infection. Br J Exp Pathol 1957;38:573-586.
22. James RC, MacLeod CJ. Induction of staphylococcal infection in mice with small inocula introduced in sutures. Br J Exp Pathol 1961;42:266-277.
23. Noble WC. Production of subcutaneous staphylococcal skin lesions in mice. Br J Exp Pathol 1965;46:254-262.
24. Taubler JH, Kapral FA. Staphylococcal population changes in experimentally infected mice: infection with sutures -absorbed and unabsorbed organisms grown in vitro and in vivo. J Infect Dis 1966;116:257-263.
25. Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger HE. Pathogenesis of foreign body infection: description and characteristics of an animal study. J Infect Dis 1982;146:487-497.
26. Bonfield TL, Colton E, Marchant RE, Anderson JM. Cytokine and growth factor production by monocytes/macrophages on protein preadsorbed polymers. J Biomed Mater Res 1992;26: 837-850.
27. Bonfield TL, Anderson JM. Functional versus quantitative comparison of IL-1 beta from monocytes/macrophages on biomedical polymers. J Biomed Mater Res 1993;27:1195-1199.
28. Cardona MA, Simmons RL, Kaplan SS. TNF and IL-1 generation by human monocytes in response to biomaterials. J Biomed Mater Res 1992;26:851-859.
29. Swartbol P, Truedsson L, Parsson H, Norgren L. Tumor necrosis factor-alpha and interleukin-6 release from white blood cells induced by different graft materials in vitro are affected by pentoxifylline and iloprost. J Biomed Mater Res 1997;36:400-406.
30. DeFife KM, Yun JK, Azeez A, Stack S, Ishihara K, Nakabayashi N, Colton E, Anderson JM. Adhesion and cytokine production by monocytes on poly(2-methacryloyloxyethyl phosphorylcholine-co-alkyl methacrylate)-coated polymers. J Biomed Mater Res 1995;29:431-439.
31. Dinarello CA. Cytokines and biocompatibility. Blood Purif 1990;8:208-213.
32. Tomford JW, Hershey CO, McLaren CE, Porter DK, Cohen DI. Intravenous therapy team and peripheral venous catheter-associated complications. A prospective control led study. Arch Intern Med 1984;144:1191.
33. Dougherty SH, Simmons RL. Infections in bionic man: the pathobiology of infections in prosthetic devices - part I. Curr Problems Surg 1982;19:221-264.
34. Dougherty SH, Simmons RL. Endogenous factors contributing to prosthetic device infections. Infect Dis Clin N Am 1989;3: 199-209.
35. Edlich RF, Panek PH, Rodeheaver GT, Turnbull LD, Kurtz LD, Edgerton MT. Physical and chemical configuration of sutures in the development of surgical infection. Ann Surg 1973;177: 679.
36. Kirkpatrick CJ, Bittinger F, Wagner M, Kohler H, van Kooten TG, Klein CL, Otto M. Current trends in biocompatibility testing. Proceedings of the Institution of Mechanical Engineers 1998. Part H. J Eng Med 1998;212:75-84.
37. Vanholder R, Ringoir S. Bioincompatibility: an overview. Int J Artif Organs 1989;12:356-365.
38. Williams DF. Progress in biomedical engineering, definitions in biomaterials. Amsterdam: Elsevier; 1987. p 54.
39. Food and Drug Administration (FDA). FDA Recognized Consensus Standards. Appendix A. 1999. (http://www.fda.gov./ cdrh/modact/recstand.html)